BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16842149)

  • 1. Structure-function based design of small molecule inhibitors targeting Rho family GTPases.
    Nassar N; Cancelas J; Zheng J; Williams DA; Zheng Y
    Curr Top Med Chem; 2006; 6(11):1109-16. PubMed ID: 16842149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design and applications of a Rac GTPase-specific small molecule inhibitor.
    Akbar H; Cancelas J; Williams DA; Zheng J; Zheng Y
    Methods Enzymol; 2006; 406():554-65. PubMed ID: 16472687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor.
    Gao Y; Dickerson JB; Guo F; Zheng J; Zheng Y
    Proc Natl Acad Sci U S A; 2004 May; 101(20):7618-23. PubMed ID: 15128949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases.
    Shang X; Marchioni F; Sipes N; Evelyn CR; Jerabek-Willemsen M; Duhr S; Seibel W; Wortman M; Zheng Y
    Chem Biol; 2012 Jun; 19(6):699-710. PubMed ID: 22726684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting rho GTPases by peptidic structures.
    Marchioni F; Zheng Y
    Curr Pharm Des; 2009; 15(21):2481-7. PubMed ID: 19601845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.
    Montalvo-Ortiz BL; Castillo-Pichardo L; Hernández E; Humphries-Bickley T; De la Mota-Peynado A; Cubano LA; Vlaar CP; Dharmawardhane S
    J Biol Chem; 2012 Apr; 287(16):13228-38. PubMed ID: 22383527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of Rho GTPase-targeting inhibitors.
    Shang X; Zheng Y
    Methods Mol Biol; 2012; 928():29-38. PubMed ID: 22956131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho GTPases and regulation of hematopoietic stem cell localization.
    Williams DA; Zheng Y; Cancelas JA
    Methods Enzymol; 2008; 439():365-93. PubMed ID: 18374178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches of targeting Rho GTPases in cancer drug discovery.
    Lin Y; Zheng Y
    Expert Opin Drug Discov; 2015; 10(9):991-1010. PubMed ID: 26087073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of EHop-016: a small molecule inhibitor of Rac.
    Dharmawardhane S; Hernandez E; Vlaar C
    Enzymes; 2013; 33 Pt A(Pt A):117-46. PubMed ID: 25033803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho GTPases: promising cellular targets for novel anticancer drugs.
    Fritz G; Kaina B
    Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways.
    Lim L; Manser E; Leung T; Hall C
    Eur J Biochem; 1996 Dec; 242(2):171-85. PubMed ID: 8973630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Rac activity alleviates lipopolysaccharide-induced acute pulmonary injury in mice.
    Yao HY; Chen L; Xu C; Wang J; Chen J; Xie QM; Wu X; Yan XF
    Biochim Biophys Acta; 2011 Jul; 1810(7):666-74. PubMed ID: 21511011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motility and invasion are differentially modulated by Rho family GTPases.
    Banyard J; Anand-Apte B; Symons M; Zetter BR
    Oncogene; 2000 Jan; 19(4):580-91. PubMed ID: 10698528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
    Boissier P; Huynh-Do U
    Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor induced activation of Rho and Rac GTPases and actin cytoskeletal reorganization in human lens epithelial cells.
    Maddala R; Reddy VN; Epstein DL; Rao V
    Mol Vis; 2003 Jul; 9():329-36. PubMed ID: 12876554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The guanine nucleotide exchange factor Tiam1 affects neuronal morphology; opposing roles for the small GTPases Rac and Rho.
    Leeuwen FN; Kain HE; Kammen RA; Michiels F; Kranenburg OW; Collard JG
    J Cell Biol; 1997 Nov; 139(3):797-807. PubMed ID: 9348295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inhibitors of Rac1 in metastatic breast cancer.
    Hernández E; De La Mota-Peynado A; Dharmawardhane S; Vlaar CP
    P R Health Sci J; 2010 Dec; 29(4):348-56. PubMed ID: 21261173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases.
    Dunford JE; Rogers MJ; Ebetino FH; Phipps RJ; Coxon FP
    J Bone Miner Res; 2006 May; 21(5):684-94. PubMed ID: 16734383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined rational design and a high throughput screening platform for identifying chemical inhibitors of a Ras-activating enzyme.
    Evelyn CR; Biesiada J; Duan X; Tang H; Shang X; Papoian R; Seibel WL; Nelson S; Meller J; Zheng Y
    J Biol Chem; 2015 May; 290(20):12879-98. PubMed ID: 25825487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.